ClinicalTrials.govpublic full text
Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation
graft vs host disease, graft-versus-host-disease, graft versus host disease, haploidentical, gvhd, crs, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 838192
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.